OliX Pharmaceuticals Inc. announced the appointment of Gordon Jiang, Aaron Hakim and Yury Popov to its Scientific Advisory Board. The board will work with OliX Pharmaceuticals executive team to refine the emerging pipeline as well as clinical strategy for the company’s assets. Yury Popov is the founder of the Popov Laboratory and an assistant professor of medicine at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School. Aaron Hakim is resident physician in internal medicine at BIDMC and clinical fellow at Harvard Medical School. He served as vice president at Great Point Partners. Gordon Jiang is transplant hepatologist and physician-scientist at BIDMC. He is the associate director of the Physician-Scientist program at BIDMC that supports careers of clinicians committed to clinical translations and basic science investigation.